Date: Tuesday 11 July
Time: 10.30am - 11.45am
Stream: Clinical practice
- Professor Graham Murray's talk, ‘Does brain structure and function causally determine mental disorder?’ will discuss whether brain structural differences cause mental disorder and whether longitudinal brain changes are a cause for concern or not.
- Professor Saeed Farooq will present evidence from large prospective studies suggesting that a number of clinical variables can predict lack of response to treatment in First Episode Psychosis (FEP) along with the findings from an internal validation of a prediction model based on clinical features that are routinely assessed in FEP. He will present an overview of literature on predicting TRS in FEP and the potential use of the prediction model in clinical practice for early detection and management of TRS.
- Professor James MacCabe will present the key results of the MRC STRATA Stratified medicine consortium, a multi-centre program aiming to develop biomarkers for treatment resistant psychosis. STRATA looks at at genetic and neurochemical differences between people with treatment resistant versus treatment responsive schizophrenia, and the dynamic changes in glutamate in patients starting antipsychotics early in the illness course. Overall the work hopes to identify those who may be at greater risk of non-response to treatment as this may help direct tailored interventions where needed.
During this session you will:
- Understand the clinical relevance of differences in brain imaging findings and their changes over time
- Understand the clinical predictors of outcome in early psychosis and any potential utility in current practice
- Understand the current evidence on the predictive capabilities of imaging and genomic biomarkers in relation to psychosis outcomes
Chair: Fiona Gaughran, National Psychosis Service, South London and Maudsley NHS Foundation Trust, London, United Kingdom
Does brain structure and function causally determine mental disorder?
Graham Murray, University of Cambridge, Cambridge, United Kingdom
Is it possible to predict treatment resistant schizophrenia at initial diagnosis of first episode psychosis - the current evidence
Saeed Farooq, Keele University, Keele, United Kingdom
Precision medicine in psychosis - where are we now?
James MacCabe, National Psychosis Service, South London and Maudsley NHS Foundation Trust, London, United Kingdom
National Psychosis Service, South London and Maudsley NHS Foundation Trust, London, United Kingdom
University of Cambridge, Cambridge, United Kingdom
Keele University, Keele, United Kingdom
National Psychosis Unit, South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, Psychology and Neuroscience, King's College London